NO20013632D0 - Steroide sulfataseinhibitorer og fremgangsmåter for å fremstille og anvende disse - Google Patents

Steroide sulfataseinhibitorer og fremgangsmåter for å fremstille og anvende disse

Info

Publication number
NO20013632D0
NO20013632D0 NO20013632A NO20013632A NO20013632D0 NO 20013632 D0 NO20013632 D0 NO 20013632D0 NO 20013632 A NO20013632 A NO 20013632A NO 20013632 A NO20013632 A NO 20013632A NO 20013632 D0 NO20013632 D0 NO 20013632D0
Authority
NO
Norway
Prior art keywords
methods
preparing
sulfatase inhibitors
steroidal sulfatase
disclosed
Prior art date
Application number
NO20013632A
Other languages
English (en)
Other versions
NO318836B1 (no
NO20013632L (no
Inventor
Pui-Kai Li
Shiro Akinaga
Chikara Murakata
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of NO20013632D0 publication Critical patent/NO20013632D0/no
Publication of NO20013632L publication Critical patent/NO20013632L/no
Publication of NO318836B1 publication Critical patent/NO318836B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0011—Unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0073—Sulfur-containing hetero ring
    • C07J71/0094—Sulfur-containing hetero ring containing sulfur and nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20013632A 1999-01-25 2001-07-24 Steroidsulfataseinhibitorer og anvendelse av det samme NO318836B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/236,842 US6288050B1 (en) 1997-07-18 1999-01-25 Steroid sulfatase inhibitors and methods for making and using the same
PCT/US2000/001723 WO2000043408A2 (en) 1999-01-25 2000-01-24 Steroid sulfatase inhibitors and methods for making and using the same

Publications (3)

Publication Number Publication Date
NO20013632D0 true NO20013632D0 (no) 2001-07-24
NO20013632L NO20013632L (no) 2001-09-03
NO318836B1 NO318836B1 (no) 2005-05-09

Family

ID=22891204

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013632A NO318836B1 (no) 1999-01-25 2001-07-24 Steroidsulfataseinhibitorer og anvendelse av det samme

Country Status (16)

Country Link
US (2) US6288050B1 (no)
EP (1) EP1147124B1 (no)
JP (1) JP3913475B2 (no)
KR (1) KR20010108127A (no)
CN (1) CN1159337C (no)
AT (1) ATE338056T1 (no)
AU (1) AU768677C (no)
BR (1) BR0008437A (no)
CA (1) CA2361168A1 (no)
DE (1) DE60030410T2 (no)
ES (1) ES2272256T3 (no)
HU (1) HUP0200096A3 (no)
MX (1) MXPA01007506A (no)
NO (1) NO318836B1 (no)
NZ (1) NZ512923A (no)
WO (1) WO2000043408A2 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476011B1 (en) * 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
JP2000309599A (ja) * 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−１，３，５（１０），１６−テトラエン誘導体
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
WO2001081364A1 (fr) * 2000-04-24 2001-11-01 Kyowa Hakko Kogyo Co., Ltd. Derives d'estra-1,3,5(10)-triene
AU2256702A (en) 2000-12-01 2002-06-11 Kyowa Hakko Kogyo Kk Composition improved in solubility or oral absorbability
US8026229B2 (en) * 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
JP2005509647A (ja) * 2001-11-06 2005-04-14 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ エストロゲン応答性乳癌の治療方法
US20050079156A1 (en) * 2001-11-06 2005-04-14 Grace Wong Method of treating endometreosis
US20040042416A1 (en) * 2002-08-27 2004-03-04 Ngo Chuong Ngoc Virtual Local Area Network auto-discovery methods
AU2003272964A1 (en) * 2002-10-09 2004-05-04 Kyowa Hakko Kogyo Co., Ltd. Remedy for hormone-dependent cancer
GB0306717D0 (en) * 2003-03-24 2003-04-30 Sterix Ltd Compound
DE602004024966D1 (de) * 2003-03-24 2010-02-25 Sterix Ltd Oestrogenderivate als steroid sulphatase inhibitoren
WO2005095437A1 (ja) * 2004-03-30 2005-10-13 Kyowa Hakko Kogyo Co., Ltd. ステロイド誘導体の製造法
AU2014352830B2 (en) 2013-11-21 2018-12-13 Concordia University, Inc. Substituted (4'-hydroxyphenyl)cycloalkane compounds and uses thereof as selective agonists of the estrogen receptor beta isoform
EP3873479A4 (en) * 2018-11-01 2022-08-03 The Regents of the University of California COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF ANDROGEN MEDIATED DISEASE

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE86393C (no)
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB9118465D0 (en) 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US5556847A (en) 1994-10-27 1996-09-17 Duquesne University Of The Holy Ghost Methods of effecting memory enhancement mediated by steroid sulfatase inhibitors
US5571933A (en) 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US5567831A (en) 1995-08-16 1996-10-22 Duguesne University Of The Holy Ghost Non-steroidal sulfatase inhibitor compounds and their method of use
DE19540233B4 (de) * 1995-10-19 2005-08-25 Schering Ag Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US5763492A (en) 1996-10-01 1998-06-09 Duguesne University Of The Holy Ghost Methods for effecting memory enhancement mediated by non-steroidal sulfatase inhibitors
US5763432A (en) 1997-01-29 1998-06-09 Sri International Steriod inhibitors of estrone sulfatase and associated pharmaceutical compositions and methods of use
US5880115A (en) * 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6046186A (en) 1997-12-24 2000-04-04 Sri International Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use

Also Published As

Publication number Publication date
NO318836B1 (no) 2005-05-09
CN1159337C (zh) 2004-07-28
EP1147124B1 (en) 2006-08-30
BR0008437A (pt) 2001-10-30
CA2361168A1 (en) 2000-07-27
JP2002535340A (ja) 2002-10-22
US6399595B1 (en) 2002-06-04
KR20010108127A (ko) 2001-12-07
EP1147124A2 (en) 2001-10-24
NZ512923A (en) 2003-01-31
NO20013632L (no) 2001-09-03
WO2000043408A2 (en) 2000-07-27
DE60030410T2 (de) 2007-08-30
DE60030410D1 (de) 2006-10-12
HUP0200096A2 (hu) 2002-07-29
JP3913475B2 (ja) 2007-05-09
CN1340056A (zh) 2002-03-13
US6288050B1 (en) 2001-09-11
AU768677B2 (en) 2003-12-18
AU768677C (en) 2004-11-11
ES2272256T3 (es) 2007-05-01
AU2625900A (en) 2000-08-07
MXPA01007506A (es) 2003-06-24
HUP0200096A3 (en) 2003-01-28
ATE338056T1 (de) 2006-09-15
WO2000043408A3 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
NO20013632D0 (no) Steroide sulfataseinhibitorer og fremgangsmåter for å fremstille og anvende disse
EP1009755A4 (en) STEROID SULFATASE INHIBITORS AND METHODS OF PRODUCING AND USING THE SAME
NO20030954L (no) Fremgangsmåte for å öke testosteron og beslektede konsentrasjoner av steroid hos kvinner
DK1090029T3 (da) 14,15-Cyclopropansteroider fra 19-norandrostan-rækken, fremgangsmåde til deres fremstilling, og farmaceutiske præparater indeholdende disse forbindelser
MXPA06000326A (es) Novedosos compuestos y composiciones que contienen esteroles y/o estanoles e inhibidores de biosintesis de colesterol, y su uso en el tratamiento o prevencion de una variedad de enfermedades y condiciones.
IL174893A0 (en) Graduated estrogen contraceptive
AU2002227184A1 (en) Methods for development and use of diagnostic and therapeutic agents
CA2387398A1 (en) Novel combination of loteprednol and antihistamines
ATE292468T1 (de) Verwendung von biogenen estrogensulfamaten zur hormonsubstitutionstherapie
EP0367576A3 (en) Estrogen nucleus derivatives for use in the inhibition of sex steroid activity
NO20053626L (no) Blanding omfattende en kombinasjon av en aromataseinhibitor, et progestin og et ostrogen for anvendelse av behandling av endomeriose
AU7667500A (en) Method and device for atomic interferometry nanolithography
DK1467762T3 (da) Anvendelse af en H1-antagonist og rimexolon som et sikkert steroid til behandling af rhinitis
NO20022449D0 (no) Mikrobiell 9-alfa-hydroksylering av steroider
AU2002217841A1 (en) Neuroactive steroid derivatives and methods of use
NO20021079L (no) Ikke-aromatiske östrogene steroider med en hydrogensubstituent i posisjon 11
YU30003A (sh) Inhibicija zavisnosti faktora rasta na ćelije tumora
IL154974A0 (en) Inhibition of the growth factor dependency of tumor cells
HUP0302405A2 (hu) Új benzofuránszármazékok
NO20021948L (no) Prevensjonspreparat basert på et progesteron og et östrogen og en fremgangsmåte for fremstilling av dette
ATE269853T1 (de) Benzoxa- und benzthiazolylsulfamate sowie ihre verwendung als steroid-sulfataseinhibitoren
DK1196428T3 (da) 11-beta-aryl-17,17-spirothiolan-substituerede steroider
NO20030606L (no) Modifisert gj¶r og anvendelser derav, n¶rmere bestemt for fremstilling avsteroidderivater
SI1414465T1 (sl) Uporaba inhibitorjev receptorja progesterona za zdravljenje na steroide rezistentnega raka dojk
NO20034273L (no) Steroidforbindelser, anvendelse av disse forbindelsene til fremstilling avmeioseregulerende medikamenter og fremgangsmåte for fremstillingav disse forbindelsene